Glucotrol Hl

Glucotrol HL: an effective cure for type 2 diabetes mellitus

Glucotrol CL (international name glipizide) is a sulfonylurea antidiabetic agent used to treat type 2 diabetes mellitus. This drug is manufactured by Pfizer in France and is available in film-coated tablets in dosages of 5 mg and 10 mg.

The active substance Glucotrol CL - glipizide - helps to increase insulin secretion by stimulating the beta cells of the pancreas. This can lower blood glucose levels and improve control of type 2 diabetes.

The use of Glucotrol CL is recommended in cases where a low-calorie diet and physical activity do not lead to sufficient control of blood glucose levels. This drug can also be used to treat diabetic microangiopathy.

However, before using Glucotrol HL, you need to familiarize yourself with the contraindications and side effects. Contraindications include hypersensitivity to glipizide, diabetic ketoacidosis, diabetic coma, juvenile diabetes mellitus type 1, as well as trauma, surgery, pregnancy and lactation.

Side effects can manifest themselves in various organs and systems: the nervous system and sensory organs, the cardiovascular system and blood, metabolism, gastrointestinal tract, skin, respiratory system, genitourinary system and others. These may include headache, dizziness, insomnia, drowsiness, nausea, vomiting, constipation, anorexia, rash, urticaria and others.

You should also consider possible interactions of Glucotrol CL with other drugs. For example, the effectiveness of this drug may be reduced by concomitant use of mineralocorticoids, glucocorticoids, amphetamines, anticonvulsants, asparaginase, calcium channel blockers, carbonic anhydrase inhibitors, and other drugs.

In general, Glucotrol HL is an effective drug for the treatment of type 2 diabetes mellitus. However, before starting to take this drug, you should consult your doctor and read the instructions for use.